New London, CT, United States of America

Molly A McGlynn

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Molly A McGlynn. Retrieved from https://idiyas.com/inventor/molly-a-mcglynn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Molly A McGlynn

Introduction

Molly A McGlynn is a notable inventor based in New London, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly through her work on piperazine derivatives. Her innovative approach has led to the development of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Molly holds a patent for piperazine derivatives, which highlights her ability to create novel compounds with potential therapeutic applications. This patent represents her commitment to innovation and her role in enhancing drug development processes.

Career Highlights

Molly A McGlynn is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to collaborate with some of the brightest minds in the industry, furthering her impact on healthcare and medicine.

Collaborations

Throughout her career, Molly has worked alongside esteemed colleagues such as Ronald P Gladue and Laura Cook Blumberg. These collaborations have enriched her professional journey and contributed to the success of her projects.

Conclusion

Molly A McGlynn is a remarkable inventor whose work in piperazine derivatives has made a significant impact in the pharmaceutical industry. Her contributions continue to inspire innovation and progress in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…